As per Intent Market Research, the Bioresorbable Polymers Market was valued at USD 1.25 billion in 2023 and will surpass USD 3.83 billion by 2030; growing at a CAGR of 17.3% during 2024 - 2030.
The bioresorbable polymers market is expected to experience significant growth from 2024 to 2030, driven by advancements in healthcare, particularly in medical applications such as drug delivery, tissue engineering, and surgical devices. Bioresorbable polymers are materials that naturally degrade within the body over time, making them ideal for temporary medical implants, drug delivery systems, and other healthcare applications. These polymers offer unique advantages, including reducing the need for surgical removal of implants and minimizing long-term foreign body reactions. As the healthcare sector continues to evolve, there is increasing demand for biocompatible, sustainable, and efficient materials that can offer controlled degradation and support various therapeutic functions. The bioresorbable polymers market is poised to grow at a robust compound annual growth rate (CAGR) during the forecast period, with the ongoing trend of personalized medicine and minimally invasive procedures contributing to its expansion.
Medical Segment is Largest Owing to Growing Demand for Surgical Implants and Drug Delivery Systems
The medical segment dominates the bioresorbable polymers market, primarily driven by the growing demand for surgical implants, drug delivery systems, and wound care applications. Bioresorbable polymers are increasingly used in medical devices such as stents, sutures, and bone fixation devices, due to their ability to degrade naturally within the body after fulfilling their function. These materials eliminate the need for additional surgeries to remove implants, which significantly reduces patient recovery times and healthcare costs. With the increasing incidence of chronic diseases, cardiovascular conditions, and orthopedic disorders, there is a growing demand for bioresorbable polymer-based implants that can aid in the healing process while minimizing complications associated with permanent implants.
The rapid adoption of bioresorbable polymers in drug delivery systems is another key factor driving growth in the medical segment. These polymers can be used to encapsulate drugs for controlled release, enhancing the effectiveness of treatments, especially for chronic conditions such as cancer and diabetes. Moreover, their biodegradability ensures that no foreign materials remain in the body, reducing the risk of long-term side effects. As the healthcare sector increasingly emphasizes patient-centric solutions and less invasive procedures, the demand for bioresorbable polymers in medical applications is expected to continue growing during the forecast period.
Packaging Segment is Fastest Growing Owing to Sustainability and Eco-Friendly Trends
The packaging segment is the fastest growing within the bioresorbable polymers market, fueled by the increasing consumer demand for sustainable and eco-friendly packaging solutions. With growing concerns about plastic pollution and the environmental impact of non-degradable materials, industries such as food and beverages, cosmetics, and pharmaceuticals are increasingly adopting bioresorbable polymers for packaging applications. These polymers offer a viable alternative to traditional plastic packaging, as they can degrade naturally without leaving harmful residues, making them an attractive choice for environmentally conscious brands.
The shift towards bio-based, biodegradable materials in packaging is further bolstered by stringent regulations and sustainability goals set by governments and organizations worldwide. Bioresorbable polymers are used in a wide range of packaging products, including single-use containers, food wraps, and medical packaging, and are particularly suitable for products that require limited shelf life or for products that will be disposed of after a single use. As companies continue to align with global sustainability goals, the demand for bioresorbable polymers in the packaging segment is expected to accelerate, making it the fastest-growing subsegment of the market.
Asia-Pacific Region Leads Market Share Owing to Growing Healthcare and Packaging Sectors
The Asia-Pacific (APAC) region leads the bioresorbable polymers market, driven by rapid growth in the healthcare, packaging, and manufacturing sectors. Countries such as China, Japan, India, and South Korea are experiencing robust demand for bioresorbable polymers due to increased healthcare spending, advancements in medical infrastructure, and a rising focus on sustainable packaging solutions. The region's burgeoning population and increasing prevalence of chronic diseases are contributing to the growing need for advanced medical devices and drug delivery systems that utilize bioresorbable polymers.
In addition to the healthcare sector, the packaging industry in APAC is also witnessing a shift toward sustainable solutions, creating new opportunities for bioresorbable polymers. Governments in the region are actively supporting environmental sustainability initiatives and enforcing regulations to reduce plastic waste, which is driving the adoption of biodegradable packaging. As the APAC region continues to urbanize and industrialize, the demand for bioresorbable polymers is expected to increase, with the region projected to maintain a leading position in the global market throughout the forecast period.
Competitive Landscape and Key Players
The bioresorbable polymers market is characterized by a competitive landscape with numerous players involved in the production, development, and commercialization of bioresorbable materials. Key players include companies such as Evonik Industries, Corbion N.V., BASF SE, DSM Biomedical, and Poly-Med Inc. These companies are at the forefront of research and development efforts aimed at enhancing the properties of bioresorbable polymers, such as improving their mechanical strength, degradation rates, and biocompatibility.
Leading players are focusing on collaborations and partnerships with healthcare providers, research institutions, and packaging companies to expand their product offerings and enter new markets. Many of these companies are also investing in sustainable manufacturing practices to meet the increasing demand for environmentally friendly solutions, particularly in the packaging industry. In addition, the increasing trend of personalized medicine and the shift toward minimally invasive medical devices are encouraging innovation in bioresorbable polymers, leading to the development of new materials that can cater to specific medical and industrial needs.
Report Objectives:
The report will help you answer some of the most critical questions in the Bioresorbable Polymers Market. A few of them are as follows:
- What are the key drivers, restraints, opportunities, and challenges influencing the market growth?
- What are the prevailing technology trends in the Bioresorbable Polymers Market?
- What is the size of the Bioresorbable Polymers Market based on segments, sub-segments, and regions?
- What is the size of different market segments across key regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa?
- What are the market opportunities for stakeholders after analyzing key market trends?
- Who are the leading market players and what are their market share and core competencies?
- What is the degree of competition in the market and what are the key growth strategies adopted by leading players?
- What is the competitive landscape of the market, including market share analysis, revenue analysis, and a ranking of key players?
Report Scope:
Report Features |
Description |
Market Size (2023) |
USD 1.25 billion |
Forecasted Value (2030) |
USD 3.83 billion |
CAGR (2024 – 2030) |
17.3% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Bioresorbable Polymers Market By Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polycaprolactone (PCL), Polydioxanone (PDO)), and By Application (Drug Delivery, Orthopedic Devices, Tissue Engineering, Cardiovascular Implants, Dental Devices) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest osf Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Bioresorbable Polymers Market, by Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Polylactic Acid (PLA) |
4.2. Polyglycolic Acid (PGA) |
4.3. Polycaprolactone (PCL) |
4.4. Polydioxanone (PDO) |
4.5. Others |
5. Bioresorbable Polymers Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Drug Delivery |
5.2. Orthopedic Devices |
5.3. Tissue Engineering |
5.4. Cardiovascular Implants |
5.5. Dental Devices |
5.6. Others |
6. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Regional Overview |
6.2. North America |
6.2.1. Regional Trends & Growth Drivers |
6.2.2. Barriers & Challenges |
6.2.3. Opportunities |
6.2.4. Factor Impact Analysis |
6.2.5. Technology Trends |
6.2.6. North America Bioresorbable Polymers Market, by Type |
6.2.7. North America Bioresorbable Polymers Market, by Application |
6.2.8. By Country |
6.2.8.1. US |
6.2.8.1.1. US Bioresorbable Polymers Market, by Type |
6.2.8.1.2. US Bioresorbable Polymers Market, by Application |
6.2.8.2. Canada |
6.2.8.3. Mexico |
*Similar segmentation will be provided for each region and country |
6.3. Europe |
6.4. Asia-Pacific |
6.5. Latin America |
6.6. Middle East & Africa |
7. Competitive Landscape |
7.1. Overview of the Key Players |
7.2. Competitive Ecosystem |
7.2.1. Level of Fragmentation |
7.2.2. Market Consolidation |
7.2.3. Product Innovation |
7.3. Company Share Analysis |
7.4. Company Benchmarking Matrix |
7.4.1. Strategic Overview |
7.4.2. Product Innovations |
7.5. Start-up Ecosystem |
7.6. Strategic Competitive Insights/ Customer Imperatives |
7.7. ESG Matrix/ Sustainability Matrix |
7.8. Manufacturing Network |
7.8.1. Locations |
7.8.2. Supply Chain and Logistics |
7.8.3. Product Flexibility/Customization |
7.8.4. Digital Transformation and Connectivity |
7.8.5. Environmental and Regulatory Compliance |
7.9. Technology Readiness Level Matrix |
7.10. Technology Maturity Curve |
7.11. Buying Criteria |
8. Company Profiles |
8.1. Abbott |
8.1.1. Company Overview |
8.1.2. Company Financials |
8.1.3. Product/Service Portfolio |
8.1.4. Recent Developments |
8.1.5. IMR Analysis |
*Similar information will be provided for other companies |
8.2. Ashland Global |
8.3. Corbion |
8.4. Evonik |
8.5. Foster |
8.6. KLS Martin |
8.7. Poly-Med |
8.8. Putnam Plastics |
8.9. Stryker |
8.10. Zeus Company |
9. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Bioresorbable Polymers Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Bioresorbable Polymers Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the Bioresorbable Polymers ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Bioresorbable Polymers Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA